Delcath: Activist has Been Approached by Two Nasdaq Listed Companies Interested in Merger or Buyout

NEW YORK - Sept. 15, 2014 - PRLog -- Dear Delcath Board of Directors, Shareholders, and Management:

Linkedto Partners was recently approached by two NASDAQ traded healthcare companies whom have expresses interest in a merger or buyout of Delcath Systems.

We will get back in contact with the Delcath Board to pass on the two interested parties contact information.  The Delcath Board has failed shareholders and the Delcath Management have also failed shareholders.   We believe with these two other public companies' interest there are there at least three potential bids for the company on the table to consider as soon as possible.

We welcome more contact with shareholders - call or email us on the number below.

Our group collectively owns about 4.9% of the company's common stock. We recently sent communications to each individual board member regarding the issues with the company and need for a sale.

We also became aware recently that over the past few years the board has had formal or informal talks with Medtronic (MDT) and other strategic buyers regarding a sale of the company.

The board of directors we believe should put it up for sale. The company has significantly underpeformed the market and shareholders have lost over $500 million from the company losing value over the past few years.

We expect the company board to take quick steps to fix the problems with the company and pursue a sale to maximize value.

Look forward to hearing back more from company board soon.

Thanks,

Neil Fromer

Linkedto Partners

Contact:

Jonathan Sanders

203.297.8268

JonathanSand@ bayttrust.com